Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the November 2, 2015, Federal Register, FDA issued a final order classifying a gastrointestinal microorganism multiplex nucleic acid-based assay into class II (special controls).
United StatesFood, Drugs, Healthcare, Life Sciences
In the November 2, 2015, Federal Register, FDA issued a final order
classifying a gastrointestinal microorganism multiplex nucleic
acid-based assay into class II (special controls). The order is
effective immediately.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
